CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Healthcare & Medical Investment Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Healthcare & Medical Investment Corp
3-3, Kandaogawa-machi
Phone: +81 352822922p:+81 352822922 CHIYODA-KU, TKY  101-0052  Japan Ticker: 34553455

Business Summary
Healthcare & Medical Investment Corp is a Japan-based investment company. The Company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The Company primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
1/31/20247/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Officer YujiFujise 11/1/2020 11/1/2020

General Information
Outstanding Shares: 359,500 (As of 1/31/2024)
Stock Exchange: TYO


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024